Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
https://doi.org/10.14412/1996-7012-2011-682
Abstract
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (international nonproprietary name meloxicam) in patients with pyrophosphate arthropathy (PA). One-month Amelotex® therapy is shown to have a good clinical effect in patients with different forms of PA, to improve quality-of-life indices, and to show good tolerability.
About the Authors
Maksim Sergeevich EliseevS A Vladimirov
Maksim Sergeyevich Eliseyev
S A Vladimirov
Review
For citations:
Eliseev MS, Vladimirov SA, Eliseyev MS, Vladimirov SA. Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2011;5(3):34-37. (In Russ.) https://doi.org/10.14412/1996-7012-2011-682
Views:
1096
Email this article 